chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The effects started off as a general weakness, then progressed into nausea and, by the end of the day, chills.  I did not have a fever.  I took my temperature and it was normal  at 98.1.  I describe it as having a cold without the congestion and runny nose.  I was fine by the next morning.
Information has been received from patient's mother who reported that her 6 month old male son with no medical history/allergies or drug reactions on approximately 27-FEB-2010 at 2 months old was vaccinated with a first dose of ROTATEQ. On 03-JUN-2010 the patient received a second dose of ROTATEQ. There was no concomitant medication. On 03-JUN-2010 after receiving the second dose the patient began to experience poor eye contact, decrease in laughter and lethargy. It was reported that the symptoms had improved but that the patient was "still not himself". The patient sought unspecified medical attention. Additional information has been requested.
The day of my arm was very sore and did not want to lift more than halfway up. The following day, I woke up with a very sore arm. By about 2pm I had body aches and a small fever. The second day, I was headachy with a sore arm.   the third day, Sunday, my arm was no longer sore, but my armpit hurt to move. At first it felt like a bra poke, but it would not go away. Monday and Tuesday, the irritant was high, but not painful. I believe this to be from a swollen lymph node. It currently feels like someone left a marble under my armpit.
Starting January 2, 2021 pain under arm pit and bicep area. The following next day noted redness on prior vaccination scarring. Lymph nodes felt swollen and pain when arm squeezed against chest.
Headaches, extreme dizziness, brain fog, vision is blurry now, need glasses now. Symptoms are not going away. I have fainting spells, sluggish, slurred speech.
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot # M002061, expiration date: 12-JAN-2018 and lot# M006724, expiration date: 08-FEB-2018) (dose, route of administration and injection site were not provided). No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Please see below for the worst symptoms that started on 4/9, but in chronological order here it is:  12 hours after receiving the vaccination:  chills, body aches, headache and feeling of drunkenness, pressure in eyes, painful gums in mouth.  On Thursday 4/8:  muscle aches, chills, tiredness, pressure  in head with drunkenness feeling again.  On Friday 4/9 at ~ 2:30pm I got a sudden feeling of coldness and started shaking and teeth were chattering uncontrollably, my lips turned blue, this lasted for about 20 to 30 minutes.  Headache and body aches continued.  Measured fever of 100.5 degF.   On Saturday 4/10:  pressure in head intensified, feeling as if someone squeezing on head.  Saturday night/early Sunday morning burning feeling in legs.  sudden sweats.  On Sunday 4/11 at time of writing, still feeling pressure in head, body aches, and chills.
About 10 days after my daughter received her first MMR vaccine, she developed a fever (103 at its highest). A couple of days later, she developed a rash of small red bumps over her trunk, upper legs, and face. The fever lasted about two days, and the rash lasted about 3 days. Our pediatrician warned us that there was a small chance we'd see a fever and rash after the vaccine, and that as long as her fever never got too high, the rash faded, and she didn't seem ill that there was no reason for concern. About 5 days after the fever began all symptoms resolved.  We did not offer any treatment as she never seemed in distress, and her fever never rose above 103.
rash over both arms, sore throat, raspy voice after 2nd shingrix.  itching n areas with rash.  hives /welts, no vessicles.
Extreme migraines, nausea, vomiting, fatigue ongoing 10 +days, symptoms worsening leading to emergency room treatment, bloodwork, and follow up with primary care, CT scan needed (results pending)
Inappropriate Age at Vaccine Administration"; shingles; This case was reported by a consumer via call center representative and described the occurrence of herpes zoster otitis externa in a 45-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles ( 6 times in ear). Previously administered products included Shingrix (1st dose received on an unknown date).   On 28th December 2019, the patient received the 2nd dose of Shingrix. In December 2019, 2 days after receiving Shingrix, the patient experienced herpes zoster otitis externa (serious criteria GSK medically significant). On an unknown date, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the herpes zoster otitis externa and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the herpes zoster otitis externa to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient's mother. The patient had mild case of shingles in her ear. The reporter stated that, the patient responded well to the treatment for the Shingles. The reporter adviced that, health care professional could follow up with medical  information. The reporter did not consent to follow up.
tingling/burning sensation of hands and feet, palpitations,  rash, weakness in hands. Started 4 days after vaccination
IPOL being administered post excursion due to a refrigerator malfunction with no reported event; Initial information received on 16-Dec-2022 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 2 months old male patient whose ipol was administered post excursion due to a refrigerator malfunction with no reported adverse event after receiving vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hib Vaccine Conj (Tet Tox) (Acthib) For Immunisation; Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular, Tetanus Vaccine Toxoid (Daptacel) For Immunisation; Rotavirus Vaccine Live Reassort Oral 5v (Rotateq) For Immunisation; Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular 5-Component, Tetanus Vaccine Toxoid (Adacel) For Immunisation; Diphtheria Vaccine Toxoid, Hib Vaccine Conj (Tet Tox), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Mrc 5), Tetanus Vaccine Toxoid (Pentacel) For Immunisation; Meningococcal Vaccine A/C/Y/W Conj (Dip Tox) (Menactra) For Immunisation; And Influenza Vaccine Inact Split 4v (Fluzone Quadrivalent) for Immunisation.  On 05-Oct-2022, the patient received a dose of 0.5 ml of suspect IPV (VERO) (lot number: V1B901M and expiry date: 02-Jun-2024) via intramuscular route in the right thigh for immunisation.  On 05-Oct-2022 the patient had a non-serious event ipol being administered post excursion due to a refrigerator malfunction with no reported adverse event (latency: same day) (poor quality product administered) following the administration of IPV (VERO).  Action taken: not applicable.  Outcome: Not Recovered / Not Resolved.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pt recv vax on 12/29/98; on 1/24/99 pt exp slurred speech, difficulty swallowing, LA weak
Information has been received from a physician via a company representative referring to a 14 year old male patient. Information about concurrent condition, medical history, drug reactions/allergies and concomitant medication were not provided. On 25-OCT-2016, the patient was vaccinated with the first dose of GARDASIL 9 (dose, lot #, expiration date and route were unknown). On the same day, the patient passed out once and had one seizure. The patient did not seek medical attention. Upon internal review, the events of "passed out once" and "had one seizure" were determined to be medically significant. The outcome of the events was unknown. The causality assessment was not reported. Additional information is not expected as no consent was provided to contact the reporter.
Within a few minutes of vaccination,  flushing/sweating, throat swelling to a level of discomfort with swallowing.  I took 1 Benadryl and then another 15 minutes later, then drove home once rxn seemed to stabilize. Took 2 more Benadryl through the course of the evening as flushing stopped but still had throat discomfort and new headache. Also took Tylenol.  In AM, allergic symptoms were resolved,  but had significant arm pain (upper arm around site was very firm and warm to the touch), mild headache, moderate fatigue, and diarrhea. This continued for another 24 hours. Took Tylenol 3 times. Felt fine by Wednesday (2 days after vaccination).
This spontaneous report was received from a nurse via company representative, referring to a 11 year old female patient. The patient's medical history, concurrent conditions, concomitant therapy, drug and allergy history were not provided. On 08-JAN-2018, the patient was vaccinated with the first dose of GARDASIL 9 (strength, dose and administration route were not reported) lot number N020352, expiration date 10-APR-2020, for immunization. On 08-JAN-2018, the patient experienced dizziness post vaccination. The patient's blood pressure was checked; however, the result was not provided. She was given some water in the office, then she felt better and was able to go home without any further adverse effects. Treatment was not given for the adverse event. The outcome of dizziness was unknown. The causality assessment between GARDASIL 9 and the aforementioned event was not provided.
NO ADVERSE EVENT NOTED OR REPORTED. Jynneos vaccine 0.1 ml was administered ID with no wheal produced and subsequent additional 0.1ml ID given with wheal production.
Right shoulder/arm pain - progressing to diagnosis of calcific tendonitis and then to a diagnosis of adhesive capsulitis.  Over past two-three days swelling at sight of injection (right deltoid) with no fever/redness... still with significant pain in the right shoulder/deltoid - unable to abduct arm (this is one month later from time of initial injection) - patient did receive cortisone injection same day as initial complaint and then a second one 3 weeks ago - with minimal improvement in symptoms - patient continues with stabbing/"twisting" pain in right deltoid and weakness to abduction of arm.
Pt came to ER c/o difficulty breathing onset 1 day prior.  Tested positive for Covid day prior.
Began with flu like symptoms. Returned to doctor on Sat. 9/22 to be diagnosed with flu. Noticed on Oct 3 increased swelling ER visit lots of inconclusive tests. Returned to primary doctor to get a new diagnosis then back for blood work. ER again then admitted on Oct 4 for increased swelling around throat and heart. Test all coming back inconclusive. She was on her monthly cycle first since receiving the shot. 4/11/08-record received-DOS 10/4-10/507-Presented with 2-3 days history of edema with acute onset of bilateral lower extremity swelling. C/O slight shortness of breath and 15-19 pound weight gain in last 2 weeks. Head, neck and mandible swollen. Difficulty swallowing.
Sporadic chest pain lasting 5-10 minutes over the course of a few hours. Cold Hands for approx two days Headache Lethargic
2wk p/vax pt devel cold;taken to MD mom reports child feet were dropped & ribs were pulled inward;1wk later pt stopped eating;31OCT95 pt taken to ER in cardiopulmonary arrest;dx diaphragmatic paralysis;dx muscular dystrophy;
103 TEMPATURE  for 4 straight days, chills, pain at injection sight, swelling and redness at injection sight, debilitating headache, nausea, sore joints, no energy
Patient states that on the night of 4/9/2021 around 10PM she was laying down and felt paralyzed and could not move for 6 hours. Patient states that she was unable to call 911 because she could not move.
received only the lyophilized component,Hib portion of the PENTACEL product, with no reported adverse event; Initial information received on 30-Jun-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 1-year-old male patient who had received only the lyophilized component,hib portion of the pentacel product, with no reported adverse event after receiving diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)].  The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (MMR) for Prophylactic vaccination.  On 30-Jun-2023, the patient received a total dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection (lot: UJ840AA) via intramuscular route in unknown administration site for Immunization.  On 30-Jun-2023 the patient had event of received only the lyophilized component,hib portion of the pentacel product, with no reported adverse event (single component of a two-component product administered) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine.  It was unknown if any lab data/tests available.  Action taken with diphtheria, tetanus, AC pertussis, IPV AND HIB vaccine (Pentacel (Vero)) was not applicable.  Outcome: unknown.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
chest and upper back pain; chest and upper back pain; lymph node swelling; hives; difficulty breathing & swallowing; difficulty breathing & swallowing; Fatigue; chest and back pain allergic reaction; This is a spontaneous report from a contactable consumer or other non hcp (patient herself) via medical information team. A 23-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number: ER8734, Expiry date: Unknown) via an unspecified route of administration in Arm Left on 26Mar2021 09:20, as dose 1, single (at the age of 23-years-old) for COVID-19 immunization. Medical history included Celiac disease from 2019 and ongoing, Hives, mouth swelling, fever, very sick for about 4 days for chicken pox vaccine. Historical vaccination includes chickenpox vaccine on unspecified date no brand name, NDC, Lot number, or expiration date known. There were no concomitant medications. On 26Mar2021, the patient experienced chest and upper back pain, chest and upper back pain, lymph node swelling, hives, difficulty breathing and swallowing, fatigue, chest and back pain allergic reaction. Patient mother reported that in response to the side effects, her daughter went to the Emergency Room. The patient underwent lab tests and procedures which included blood test: normal on Mar2021 States that her Potassium was a little low as was her Alkaline Phosphatase. States it was not drastic, just low. Then states well, it was normal; just low, echocardiogram: normal on Mar2021 no more information available, x-ray: normal on Mar2021 no more information available. Patient was not taken to physician office. Patient wants to know if she will get the second dose. The outcome for events chest and upper back pain, lymph node swelling, hives, difficulty breathing & swallowing recovered on 27Mar2021, outcome of fatigue was recovered and lasted until 28Mar2021 or 29Mar2021, outcome of event for chest and back pain allergic reaction was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Instant swelling and redness at injection site. Ice pack applied. BENADRYL given one per day.
localized rxn to vax w/in 10min of inj consisting of erythematous rash w/edema;pt observed;rash began spreading from 3-4" size up to about 5-6" size w/itching;itching persisted;hard not on arm @ inj site;not feeling well-laid around;
Burning eyes; Watery eyes; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 04May2021 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and fibromyalgia. The patient previously had taken sulfa drugs, cephalosporins, keflex, ceclor, yogurt and  latex on unknown dates and experienced allergy. Concomitant medications included cyclobenzaprine hydrochloride (FLEXERIL), metformin (MANUFACTURER UNKNOWN), insulin detemir (LEVEMIR), exenatide (BYDUREON) and dapagliflozin propanediol monohydrate (FARXIGA), all for unknown indications from an unknown dates. Prior to the vaccination, the patient was  not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 16:00, the patient experienced burning eyes and watery eyes. The clinical outcome of the events of watery eyes and burning eyes was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
EXTREME vertigo. Hit me 7 days after first shot, continued for 2 weeks but off and on and manageable.  As soon as I got my second shot 10/04/21 at 9am, that night at 8:30pm the vertigo was back full force and I haven't been the same since.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 68-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (in spring 2018). On 9th November 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 9th November 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On 10th November 2018, the patient experienced influenza-like symptoms, fever, cough, chills, fatigue and headache. In November 2018, the patient experienced diaphoresis. On an unknown date, the outcome of the influenza-like symptoms, fever, cough, diaphoresis, chills, fatigue and headache were not recovered/not resolved and the outcome of the pain in arm was recovered/resolved. The reporter considered the influenza-like symptoms, fever, cough, diaphoresis, chills and fatigue to be related to SHINGRIX. It was unknown if the reporter considered the headache and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. The patient's left arm was sore from the vaccine. On Saturday morning the patient woke up with flu like symptoms, fever, coughing, chills, fatigue and headache. The patient stated that the fever got up to 100 degree F. On the same day Saturday night, in the middle of the night the patient experienced a major episode of diaphoresis and her sheets were soaked with sweat. The patient stated that she had another episode of diaphoresis on the day of reporting approximately 30 minutes before she called GlaxoSmithKline. The patient had consented to follow up. The patient gave contact details of the physician.
Pulsate tinnitus; Slightly itchy fair pink (2x3 inch) rash; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Pulsate tinnitus) and RASH PRURITIC (Slightly itchy fair pink (2x3 inch) rash) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tinnitus (Typically resolves within days).   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced RASH PRURITIC (Slightly itchy fair pink (2x3 inch) rash). On an unknown date, the patient experienced TINNITUS (Pulsate tinnitus). On 11-Mar-2021, RASH PRURITIC (Slightly itchy fair pink (2x3 inch) rash) had resolved. At the time of the report, TINNITUS (Pulsate tinnitus) outcome was unknown.            Concomitant medications included muscle relaxer to relieve tinnitus symptoms.  Treatment for the event included muscle relaxer. Patient received her second Moderna dose 10Mar2021. Patient reports development of a slightly itchy, "fair pink" (2x3 inch) rash post second dose lasting one day [resolution date 11Mar2021]. Patient reports continued pulsate tinnitus. Patient has a PMH significant for pulsate tinnitus, that typically resolves within days. Patient reports administering a muscle relaxer to relieve tinnitus symptoms, to not avail.   This case was linked to MOD-2021-046367 (Patient Link).
pt states that a couple of days after taking the vax she developed dark purple circles under each eye.  Her eyes are swollen with bags under them.  The  whites of her eyes are very red and burning.  Pt still has these symptoms.  Pt has not taken any meds or put any drops in her eyes since this started and she is waiting for a CB from her PCP.
Breakthrough case admission after three vaccines Moderna 3/4/21 Lot# 030A21A;  Moderna 3/31/21 Lot# 025B21A;  Moderna 11/30/21 Lot# 045J21A
I have sinusitus and eacj time I have taken the vaccines it seems to bring on a sinus infection, and severe sinus infections give me flu like systems, and it takes several days to recover.  I have had 2 regular vaccines - Moderna, 2 Moderna boosters, and the 3rd booster was the PFizer vaccine.  I hope there are studies or will be to see if there is any correlation from vaccine and my sinuses.
On the 5th day after my vaccine, I first experienced a very itchy, red warm lump on the back of my left leg (just above my knee, but, on the back of my leg). And then a day later, a 2nd itchy, red warm lump appeared very close to the 1st lump. They each lasted a day or two.  They were very irritating...very honestly, they would wake me up at night due to itchiness. And then on the 8th day after my vaccine, my left arm (near my injection site) started looking exactly the same...however, it was terribly red...as well as itchy and very hot to the touch; the redness started small, but then grew over the course of the next day, and spread below my elbow (I would estimate 7 inches or so).  It was horrible. I iced it all day long. It was terribly uncomfortable...it made my whole body feel warm and uncomfortable. I went to the doctor for something unrelated, and the nurse mentioned that she had a similar experience (and also had the Moderna vaccine)...otherwise, I would not have pieced it all together. By the 10th day, all 3 of the lumps were gone. To be honest, I dread my 2nd vaccine (this week) due to the discomfort that the lumps caused.